RCKT
Price:
$11.82
Market Cap:
$1.26B
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated ...[Read more]
Industry
Biotechnology
IPO Date
2015-02-18
Stock Exchange
NASDAQ
Ticker
RCKT
According to Rocket Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Rocket Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), RCKT's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Rocket Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Rocket Pharmaceuticals, Inc. (RCKT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Rocket Pharmaceuticals, Inc.’s Dividend Yield is less than uniQure N.V. (0%), less than Rhythm Pharmaceuticals, Inc. (0%), less than Solid Biosciences Inc. (0%), less than MeiraGTx Holdings plc (0%), less than Vaxcyte, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Merus N.V. (0%), less than Sutro Biopharma, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Pliant Therapeutics, Inc. (0%), less than Dyne Therapeutics, Inc. (0%), less than Cytokinetics, Incorporated (0%), less than Revolution Medicines, Inc. (0%), less than REGENXBIO Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Replimune Group, Inc. (0%), less than Mirum Pharmaceuticals, Inc. (0%), less than Viridian Therapeutics, Inc. (0%), less than Inozyme Pharma, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $846.18M | |
0% | $3.42B | |
0% | $166.21M | |
0% | $481.42M | |
0% | $10.66B | |
0% | $243.42M | |
0% | $1.11B | |
0% | $2.91B | |
0% | $157.50M | |
0% | $598.53M | |
0% | $814.83M | |
0% | $2.45B | |
0% | $5.73B | |
0% | $8.07B | |
0% | $368.62M | |
0% | $1.27B | |
0% | $942.51M | |
0% | $2.03B | |
0% | $1.52B | |
0% | $186.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rocket Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rocket Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Rocket Pharmaceuticals, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Rocket Pharmaceuticals, Inc. (RCKT)?
What is the highest Dividend Yield for Rocket Pharmaceuticals, Inc. (RCKT)?
What is the 3-year average Dividend Yield for Rocket Pharmaceuticals, Inc. (RCKT)?
What is the 5-year average Dividend Yield for Rocket Pharmaceuticals, Inc. (RCKT)?
How does the current Dividend Yield for Rocket Pharmaceuticals, Inc. (RCKT) compare to its historical average?